Abnormal Adiponectin Level C4073126
Abnormal levels of adiponectin, a hormone produced by fat cells that helps regulate metabolism. It may be linked to conditions like diabetes or obesity. Management typically involves treating underlying conditions and lifestyle changes.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Shortness of breath
Difficulty breathing or feeling winded with minimal exertion, which may indicate cardiovascular complications.
Seek immediate medical attention if shortness of breath is severe or occurs at rest, as it may indicate a serious cardiovascular condition.
Chest discomfort
Pressure, tightness, or pain in the chest area that may occur with activity or at rest.
Seek emergency medical care immediately if chest pain is severe, crushing, or accompanied by shortness of breath, sweating, or radiating pain to the arm or jaw.
Persistent fatigue
(constitutional)Persistent feeling of tiredness and low energy that doesn't improve with rest, often related to metabolic dysfunction.
Frequency: 70-80% of patients
Unexplained weight gain
(constitutional)Increased body weight, particularly around the abdomen, that occurs without significant changes in diet or activity level.
Frequency: 75-85% of patients
Increased appetite
(gastrointestinal)Persistent feelings of hunger and difficulty feeling full, often related to leptin resistance and metabolic dysregulation.
Frequency: 65-75% of patients
Elevated blood pressure
(cardiovascular)Higher than normal blood pressure readings, often related to insulin resistance and metabolic syndrome.
Frequency: 50-60% of patients
Acanthosis nigricans
(dermatologic)Dark, thickened patches of skin, typically appearing on the neck, armpits, or groin, indicating insulin resistance.
Frequency: 40-50% of patients
Difficulty losing weight
(constitutional)Persistent difficulty losing weight despite diet and exercise efforts, related to metabolic and hormonal imbalances.
Frequency: 60-70% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Mediterranean Diet Intervention
Adoption of a Mediterranean-style dietary pattern rich in olive oil, fruits, vegetables, whole grains, and lean proteins has been shown to improve adiponectin levels and metabolic health markers.
Regular Physical Exercise Program
Consistent aerobic exercise training has been demonstrated to increase adiponectin secretion and improve insulin sensitivity. A combination of moderate-intensity continuous training and interval training is recommended.
Additional treatment options
Weight Management Through Caloric Restriction
Modest weight reduction of 5-10% of body weight can significantly improve adiponectin levels and reduce associated metabolic risks. Focus on sustainable lifestyle changes rather than rapid weight loss.
lifestyleThiazolidinedione Therapy
Thiazolidinedione medications act as PPAR-gamma agonists and can increase adiponectin expression. These are typically reserved for patients with metabolic syndrome or type 2 diabetes when lifestyle measures are insufficient.
medicationMetabolic Parameter Tracking
Regular monitoring of metabolic markers including lipid profile, fasting glucose, HbA1c, and inflammatory markers alongside adiponectin levels helps assess treatment response and cardiovascular risk.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Adiponectin Level C4073126?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-1792.
Katsi V, Oikonomou D, Vamvakou G, et al. Adiponectin and cardiovascular disease: A biomarker and therapeutic target. Hellenic J Cardiol. 2021;62(5):352-358.
Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(6):1321.
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S20-S42.
Gao H, Fall T, van der Harst P, et al. Association of adiponectin with cardiovascular disease and mortality: The Swedish Malmo Diet and Cancer Study. Eur Heart J. 2009;30(7):805-814.
Finucane FM, Luan J, Wareham NJ, et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia. 2009;52(11):2345-2349.
Soedling H, Ekelund U, Wareham NJ, Langenberg C. Adiponectin and incident type 2 diabetes: An epidemiological study within the EPIC-InterAct. Cardiovasc Diabetol. 2015;14:13.
Endocrine Society. Endocrine Society Clinical Practice Guideline on the identification and management of metabolic dysfunction in obesity. J Clin Endocrinol Metab. 2024;109(1):1-30.
Liu M, Liu F. Regulation of adiponectin multimerization, signaling and function. Best Pract Res Clin Endocrinol Metab. 2014;28(1):25-31.
International Diabetes Federation. IDF Consensus Worldwide Definition of Metabolic Syndrome. Brussels: International Diabetes Federation; 2006.
Medication Comparisons
Compare medications used to treat Abnormal Adiponectin Level C4073126. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy